International Campaign to Promote and Revitalise Academic Medicine

1
International Campaign to Promote and Revitalise
Academic Medicine
2
Sponsors include

• BMJ Publishing Group
• Lancet
• CMAJ
• Dutch Journal of Medicine
• Medical Journal of Australia
• Croatian Medical Journal
• 20 other journal partners
• Other international organisations
• Invitation to readers all over the world to join
  us in this exciting enterprise

3
The Charge

• What are the roles of academic medicine
  throughout the world?
• Is academic medicine fulfilling these roles?
• If not, why not?
• What needs to be done to permit/force academic
  medicine to fulfill its roles?

4
Why is this different from the many national
reports?

• Global perspective
• Can we do better to get the best of the best
  into academic medicine?
• Money is NOT the prime aim
• Values driven
• Customer centred
• Spectrum Knowledge Creation and
  Translation incl Behaviour Change
• Forward looking Systems Thinking
• Appreciation of the crucial importance of
  developing a convincing story re making a
  difference

5
What is the problem challenge?

6
Is the existing structure of academic medicine
still fundamentally sound?

• Many perceived failures nominated, including
• Failure to serve the public good Axis of power
  in academic medicine disenfranchises the public /
  patients.
• Lack of a global perspective / culture of
  science Neglect of millions of preventable
  deaths each year.
• Unnecessary dichotomy between education and
  research
• Failing to integrate biomedical approach with
  systems, behavioural, and social scientific
  frameworks.
• Economic imperatives rather than health needs
  drive governmental and industry investment in
  academic medicine.
• Various shortcomings in medical education.
• Inadequate numbers of and career paths for
  well-trained medical academics.

7
Why is academic medicine failing to fulfil its
roles? Many of the reasons will be economic, but
we need to examine ethical and moral explanations
as well

• Nominated ideas include
• Inadequate leadership.
• Failure to translate basic discoveries into
  benefits for patients
• Inappropriate incentives to take up or maintain
  an academic career (especially among women).
• Deficient mentoring for aspiring academics.
• Lack of appreciation of the benefits of academic
  medicine by elected representatives.
• Poor integration with other health services.

8
What are the alternatives?

• For each failure, what ought to be done about it?
• We will identify and develop international
  collaborative strategies for how academic
  medicine can contribute to national and global
  health
• These strategies will be combined and formulated
  into concrete proposals for action.

9

• Given current economic constraints in both
  high-income and low-income countries, special
  attention will go to strategies that call for no
  additional funding. We will also welcome
  strategies that call for the reallocation of
  current funding.

10
The approach

• Our approach will be inclusive and is designed to
  elicit a broad input of opinions and perspectives
• We aim to build consensus by inviting a wide
  range of global stakeholders to contribute their
  views
• The focus is on the customers of academic
  medicinepatients, politicians, the public,
  professionals.
• All will be encouraged to contribute their views
  to the project website

11
International Working Party

• The pivotal group is an international working
  party
• 20 members, representing 14 countries, identified
  from over 80 superb applications
• Composition
• Junior to mid level clinical scientists nominated
  by influential mentors
• Global representation
• Gender balance

12
Working Party

• Tahmeed Ahmed - Bangladesh
• Shally Awasthi- India
• Mark Clarfield - Israel
• Lalit Dandona - India
• Amanda Howe - England
• John Ioannidis - Greece
• Edwin Jesudason - England
• Wendy Levinson - Canada
• Youping Li - China
• Juan Manuel Lozano - Columbia
• Ana Marusic - Croatia
• Idris Mohammed - Nigeria
• Gretchen Purcell - United States
• Karen Sliwa-Hahnle - South Africa
• Sharon Straus - Canada
• Tessa Tan Torres Philippines, Switzerland
• Tim Underwood - England
• Robyn Ward - Australia
• Michael Wilkes - United States

13
Advisory groups

• Representing the interests of the customers of
  academic medicine
• 2-3 co conveners and 8-10 members each
• Academics group
• Professionals group
• Government and policy group
• Patients group
• Students group
• Business/industry group
• Funders Forum
• Journal editors group

14
Regional Panels

• Regional consultations will be coordinated by
  Stephen Leeder
• Australasia
• China
• Europe
• Latin America and Caribbean
• Middle East and Northern Africa
• North America
• South Asia
• Southern Africa
• Or other regional breakdown

15
Enabling committee

• Influential academic medicine advisors
• Linked to regional panels
• Experience with previous academic medicine
  consultations and with key customers and
  stakeholders
• Will assist with credibility and visibility of
  the campaign
• Will advise working party and planning committee

16
The process

• Working Party Retreat 13- 16 JuneInaugural
  Meeting 14 June
• Both to focus on 4 questions
• What are the roles of academic medicine
  throughout the world?
• Is academic medicine fulfilling these roles?
• If not, why not?
• What needs to be done to permit/force academic
  medicine to fulfill its roles?

17
What we want to accomplish today Nominate issues
for the working party

• Morning Session Small group work on nominating
  issues for questions 1 and 2
• 1. What are the roles of academic medicine
  throughout the world?
• 2. Is academic medicine fulfilling these roles?

18
What we want to accomplish today Nominate issues
for the working party

• Afternoon Session Small group work on nominating
  issues for questions 3 and 4
• 3. If academic medicine is not fulfilling the
  roles identified in the morning, why not?
• 4. What needs to be done to permit/force academic
  medicine to fulfill its roles?

19
Timeline after this week

• Working Party Monthly Meetings by teleconference
  for 12 months
• Advisory group and regional panel consultations
  July through December 2004
• Special theme issue BMJ October 2004
• Recommendations Report and Meeting Summer or Fall
  2005

20
I look forward to a productive day!
21
(No Transcript)
22
The structure
Regional representation
Representing the customers
23
The structure
Regional representation
Representing the customers